Insider · CIK 0002147180
Seymour Howard Fein
Files at OTLC (Oncotelic Therapeutics, Inc.). First filing -, latest -.
In brief
Seymour Howard Fein files SEC Form 4 as officer at OTLC (Oncotelic Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Seymour Howard Fein has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | OTLC Oncotelic Therapeutics, Inc. | AGrant or award Restricted stock Unitsderivative | +250 | $0.00 | $0 | 250 | Jul 23, 2026 |
Questions about Seymour Howard Fein
Answered from the filings on this page, as of the latest one.
Is Seymour Howard Fein buying or selling?
Seymour Howard Fein has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Seymour Howard Fein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Seymour Howard Fein has 0.
Where does Seymour Howard Fein file Form 4?
Seymour Howard Fein has filed Form 4 at OTLC (Oncotelic Therapeutics, Inc.) as CRO/CMO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.